03:10 PM EST, 12/19/2025 (MT Newswires) -- Sanofi ( SNY ) said Friday it has reached an agreement with the US government to lower medicine costs.

Medicaid programs can access certain Sanofi ( SNY ) medicines at the same prices available to other high-income nations, cutting prices by an average of 61% for some medicines that treat diabetes, cardiovascular and neurological conditions and cancer, the company said.

Sanofi ( SNY ) also said it will offer consumers access to lower-cost medicines via TrumpRx.gov and other direct-to-patient platforms at an average savings of nearly 70% on some medicines to treat infections and cardiovascular and diabetic conditions.

The agreement provides a three-year period free from Section 232 tariffs on products imported by Sanofi ( SNY ), it added.

Sanofi ( SNY ) also said the deal does not impact its Take the Lead growth strategy or financial outlook during the agreement period.

Price: 48.36, Change: +0.37, Percent Change: +0.77